Meury William

CIK 00015367785 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001536778

Recent Transactions

50 trades

Award
INCYTE CORP$INCY
Common Stock
2025-07-02+36,101→ 36,101 total
Award
INCYTE CORP$INCY
Performance Shares
2025-07-02+108,303→ 108,303 total
Award
INCYTE CORP$INCY
Performance Shares
2025-07-02+125,000→ 125,000 total
Award
INCYTE CORP$INCY
Employee Stock Option (right to buy)
2025-06-26+110,630→ 110,630 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2025-02-05+25,000→ 90,000 total
Disposition to Issuer
Karuna Therapeutics, Inc.
Common Stock
2024-03-18$330.00/sh−10,342→ 19,037 total
Disposition to Issuer
Karuna Therapeutics, Inc.
Restricted Stock Units
2024-03-18$330.00/sh−38,688→ 0 total
Disposition to Issuer
Karuna Therapeutics, Inc.
Option (right to buy)
2024-03-18$136.81/sh−63,065→ 0 total
Disposition to Issuer
Karuna Therapeutics, Inc.
Common Stock
2024-03-18$330.00/sh−19,037→ 0 total
Award
Karuna Therapeutics, Inc.
Restricted Stock Units
2024-02-13+38,688→ 38,688 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2024-02-07+17,000→ 65,000 total
Tax Payment
Karuna Therapeutics, Inc.
Common Stock
2023-12-28$316.30/sh−8,694→ 29,379 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2023-08-02−35,000→ 0 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2023-08-02−24,000→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-08-02$20.46/sh−24,000→ 48,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-08-02$7.88/sh+24,000→ 72,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-08-02$7.11/sh+35,000→ 83,000 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-08-02$20.46/sh−35,000→ 48,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Stock Options (Right to buy)
2023-08-02−24,000→ 0 total
Sale
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-08-02$20.45/sh−24,000→ 48,000 total
Exercise/Conversion
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-08-02$9.47/sh+24,000→ 72,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2023-02-02+16,000→ 48,000 total
Award
Karuna Therapeutics, Inc.
Common Stock
2023-01-03+38,073→ 38,073 total
Award
Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
2023-01-03+63,065→ 63,065 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2022-02-02+16,000→ 32,000 total
Award
Syndax Pharmaceuticals Inc$SNDX
Common Stock
2021-02-03+16,000→ 16,000 total
Disposition to Issuer
Allergan plc
Stock Options
2020-05-08−509→ 0 total
Disposition to Issuer
Allergan plc
Ordinary Shares, par value $0.0001
2020-05-08−7,434→ 0 total
Disposition to Issuer
Allergan plc
Stock Options
2020-05-08−10,089→ 0 total
Disposition to Issuer
Allergan plc
Stock Options
2020-05-08−16,081→ 0 total
Disposition to Issuer
Allergan plc
Stock Options
2020-05-08−1,246→ 0 total
Disposition to Issuer
Allergan plc
Stock Options
2020-05-08−1,387→ 0 total
Disposition to Issuer
Allergan plc
Stock Options
2020-05-08−19,278→ 0 total
Disposition to Issuer
Allergan plc
Stock Options
2020-05-08−1→ 0 total
Disposition to Issuer
Allergan plc
Restricted Stock Units
2020-05-08−25,201→ 0 total
Disposition to Issuer
Allergan plc
Stock Options
2020-05-08−21,621→ 0 total
Disposition to Issuer
Allergan plc
Performance Stock Units
2020-05-08−26,506→ 0 total
Disposition to Issuer
Allergan plc
Stock Options
2020-05-08−12,304→ 0 total
Tax Payment
Allergan plc
Ordinary Shares, par value $0.0001
2020-04-03$175.71/sh−855→ 32,635 total
Award
Allergan plc
Ordinary Shares, par value $0.0001
2020-03-02$193.84/sh+21,667→ 33,490 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2020-02-12+24,000→ 24,000 total
Tax Payment
Allergan plc
Ordinary Shares, par value $0.0001
2019-12-31$191.17/sh−1,504→ 11,823 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2019-06-10+24,000→ 24,000 total
Tax Payment
Allergan plc
Ordinary Shares, par value $0.0001
2019-04-03$145.71/sh−871→ 13,327 total
Tax Payment
Allergan plc
Ordinary Shares, par value $0.0001
2018-12-31$133.66/sh−1,531→ 14,198 total
Award
Syndax Pharmaceuticals Inc$SNDX
Stock Option (Right to Buy)
2018-09-25+35,000→ 35,000 total
Exercise/Conversion
Allergan plc
Ordinary Shares, par value $0.0001
2018-05-17$68.11/sh+1,467→ 20,369 total
Exercise/Conversion
Allergan plc
Ordinary Shares, par value $0.0001
2018-05-17$68.11/sh+19,785→ 40,154 total
Sale
Allergan plc
Ordinary Shares, par value $0.0001
2018-05-17$154.59/sh−24,425→ 15,729 total
Exercise/Conversion
Allergan plc
Incentive Stock Option
2018-05-17−1,467→ 0 total

Companies

Recent Filings

Address

C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE

NEW YORK, NY, 10022

View on SEC.gov